Key facts
- This page summarizes George A. Scangos's Form 4 filing for Vir Biotechnology, Inc. (VIR).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 03 Jun 2024, 12:17.
George A. Scangos - 30 May 2024 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)
- Reporting relationship
- Director
- Issuer ticker
- VIR
- Reported as of
- 30 May 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 03 Jun 2024, 12:17:53 UTC
- Prior SEC filing
- 31 May 2024
- Next SEC filing
- 07 Jun 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Vanina de Verneuil, Attorney-In-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
George A. Scangos filed Form 4 for Vir Biotechnology, Inc. (VIR) on 03 Jun 2024.
Change
- Previous filing in this sequence was filed on 31 May 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
VIR
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +8,000
- Change %
- +7.1%
- Price
- $0.000000
- Shares after
- 120,989
- Date
- 30 May 2024
- Ownership
- Direct
VIR
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,750,000
- Date
- 30 May 2024
- Ownership
- See footnote
- Footnotes
- F1
VIR
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,750,000
- Date
- 30 May 2024
- Ownership
- See footnote
- Footnotes
- F2
VIR
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 33,629
- Date
- 30 May 2024
- Ownership
- See footnote
- Footnotes
- F3
VIR
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 179,930
- Date
- 30 May 2024
- Ownership
- See footnote
- Footnotes
- F4
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
VIR
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +16,000
- Change %
- Price
- $0.000000
- Shares after
- 16,000
- Date
- 30 May 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 16,000
- Exercise price
- $10.39
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
The shares are held in the name of the George A Scangos 2023 Annuity Trust, of which the reporting person and his spouse are Trustees.
Footnote F2
The shares are held in the name of Leslie Wilson 2023 Annuity Trust, of which the reporting person and his spouse are Trustees.
Footnote F3
The shares are held in the name of George A. Scangos, as Trustee of the Scangos-Wilson Family Trust dated May 12, 2011.
Footnote F4
The shares are held in the name of the Scangos 2018 Grandchildren's Trust, of which the reporting person and his spouse are Trustees.